ArticleNature communications2025
Mid-gestational cell-type-specific transcriptomic signatures in the prefrontal and superior temporal cortex in Down syndrome.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-Omics Reveals Dysregulated Neurotransmitter Systems in Aging and CNS Disorders.Aging cell · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cellular and molecular mechanisms underlying cortical alterations during early fetal development in Down syndrome (DS) remain largely unexplored. Here, we perform single-nucleus RNA sequencing (snRNA-seq) analysis on mid-gestational DS and control brain samples, including prefrontal cortex (PFC) and superior temporal plane cortex (STP). Through comparative spatiotemporal analyses, we decode cell-type- and region-specific transcriptional alterations associated with chr21 abnormalities, including a disrupted inhibitory-to-excitatory balance during mid-gestational development. RUNX1 and APP emerge as the most significantly dysregulated chromosome21 genes in the PFC and STP, respectively. Abnormal cortical distribution of excitatory neurons in both regions is potentially driven by dysregulated neuronal migration genes and impaired lactylation metabolism. Moreover, glial cells modulate the differentiation and migration of excitatory neurons through multiple intercellular signaling pathways. These findings provide critical insights into the pathogenesis of DS-related mid-gestational cortical abnormalities and offer valuable resources for disease modeling and development of spatiotemporally targeted therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.